Published in HSS J on September 01, 2005
Bone: formation by autoinduction. Science (1965) 13.34
Morbidity at bone graft donor sites. J Orthop Trauma (1989) 4.99
Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am (2002) 3.64
The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976) (2000) 2.87
Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) (2002) 2.74
Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater (1991) 2.74
Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976) (2002) 2.70
Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech (2002) 2.54
Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br (1989) 2.43
Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A (1981) 2.43
OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J (1990) 2.25
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun (1990) 1.88
A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis. Spine (Phila Pa 1976) (2004) 1.86
Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J (2005) 1.74
A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients. Spine (Phila Pa 1976) (1994) 1.59
Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem (1989) 1.57
Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem (1990) 1.42
2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion. Spine (Phila Pa 1976) (2001) 1.35
Pseudarthrosis of the spine. Clin Orthop Relat Res (1992) 1.33
Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun (1991) 1.32
The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine (Phila Pa 1976) (2003) 1.24
Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion device. Spine (Phila Pa 1976) (1999) 1.24
Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells. J Spinal Disord Tech (2004) 1.14
A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics (2003) 1.12
Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J Histochem Cytochem (1995) 1.07
Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol (1999) 1.06
A pilot safety and efficacy study of OP-1 putty (rhBMP-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J (2003) 1.05
The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model. Spine (Phila Pa 1976) (1999) 1.03
In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine (Phila Pa 1976) (1994) 1.02
Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord (1999) 1.01
Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) (1995) 1.00
A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J (2005) 0.99
Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord (1998) 0.99
Immunolocalization of bone morphogenetic protein and its receptors in degeneration of intervertebral disc. Spine (Phila Pa 1976) (1999) 0.96
Improved lumbar vertebral interbody fusion using rhOP-1: a comparison of autogenous bone graft, bovine hydroxylapatite (Bio-Oss), and BMP-7 (rhOP-1) in sheep. Spine (Phila Pa 1976) (2001) 0.94
Bioactive factors for bone tissue engineering. Clin Orthop Relat Res (1999) 0.93
Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine (Phila Pa 1976) (1999) 0.93
Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion. Spine (Phila Pa 1976) (2002) 0.93
Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine (Phila Pa 1976) (2002) 0.92
Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms. J Cell Physiol (1998) 0.88
OP-1 enhances dendritic growth from cerebral cortical neurons in vitro. Exp Neurol (1999) 0.88
Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord (1997) 0.88
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. Spine (Phila Pa 1976) (1999) 0.86
Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine (Phila Pa 1976) (1996) 0.86
Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine (Phila Pa 1976) (1997) 0.86
Osteogenic protein-1 differentially regulates the mRNA expression of bone morphogenetic proteins and their receptors in primary cultures of osteoblasts. J Cell Physiol (2000) 0.86
Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine (Phila Pa 1976) (1995) 0.85
Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. Spine (Phila Pa 1976) (2001) 0.85
Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction. Spine J (2003) 0.85
Osteogenic protein-1 mRNA in the uterine endometrium. Biochem Biophys Res Commun (1997) 0.85
Intertransverse process lumbar arthrodesis with allogeneic fresh-frozen bone graft. Clin Orthop Relat Res (1993) 0.85
Experimental spinal fusion with decalcified bone matrix and deep-frozen allogeneic bone in rabbits. Clin Orthop Relat Res (1982) 0.83
Response of bone marrow stroma cells to demineralized cortical bone matrix in experimental spinal fusion in rabbits. Clin Orthop Relat Res (1988) 0.83
Osteogenic protein-1 is required for mammalian eye development. Biochem Biophys Res Commun (1996) 0.83
Factors predicting hospital stay, operative time, blood loss, and transfusion in patients undergoing revision posterior lumbar spine decompression, fusion, and segmental instrumentation. Spine (Phila Pa 1976) (2002) 2.23
The biology of bone grafting. J Am Acad Orthop Surg (2005) 1.85
Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am (2005) 1.68
Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine (Phila Pa 1976) (2006) 1.67
The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature. Am J Orthop (Belle Mead NJ) (2008) 1.63
Major vascular injury during anterior lumbar spinal surgery: incidence, risk factors, and management. Spine (Phila Pa 1976) (2007) 1.44
Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine (Phila Pa 1976) (2002) 1.34
Outcome of revision discectomies following recurrent lumbar disc herniation. Spine (Phila Pa 1976) (2006) 1.32
Summary statement: emerging techniques for treatment of degenerative lumbar disc disease. Spine (Phila Pa 1976) (2003) 1.20
Alendronate inhibits spine fusion in a rat model. Spine (Phila Pa 1976) (2005) 1.13
A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Orthopedics (2003) 1.12
Accuracy of single-time, multilevel registration in image-guided spinal surgery. Spine J (2005) 1.05
Low back pain recollection versus concurrent accounts: outcomes analysis. Spine (Phila Pa 1976) (2002) 1.02
High-dose alendronate uncouples osteoclast and osteoblast function: a study in a rat spine pseudarthrosis model. Clin Orthop Relat Res (2004) 1.01
Conjunctival T-cell lymphoma: a clinicopathologic case report. Ophthalmology (2006) 0.99
Use of osteopromotive growth factors, demineralized bone matrix, and ceramics to enhance spinal fusion. J Am Acad Orthop Surg (2005) 0.93
Cervical epidural abscess after epidural steroid injection. Spine (Phila Pa 1976) (2004) 0.89
Discordantly high spinal bone mineral density values in patients with adult lumbar scoliosis. Spine (Phila Pa 1976) (2006) 0.83
Mönckeberg medial calcific sclerosis mimicking giant cell arteritis clinically. Can J Ophthalmol (2013) 0.82
BMPs and gene therapy for spinal fusion: summary statement. Spine (Phila Pa 1976) (2003) 0.82
Cost effectiveness analysis of graft options in spinal fusion surgery using a Markov model. J Spinal Disord Tech (2012) 0.81
Cytomegalovirus retinitis mimicking intraocular lymphoma. Clin Ophthalmol (2008) 0.80
Nitric oxide modulates recombinant human bone morphogenetic protein-2-induced corticocancellous autograft incorporation: a study in rat intertransverse fusion. Eur Spine J (2010) 0.80
A novel method for the quantitative evaluation of lumbar spinal stenosis. HSS J (2006) 0.80
Melkersson-Rosenthal syndrome presenting with isolated bilateral eyelid swelling: a clinicopathologic correlation. Can J Ophthalmol (2011) 0.79
The current status of lumbar total disc replacement. Orthop Clin North Am (2004) 0.78
Threaded cortical bone dowels in lumbosacral arthrodesis: a review. Clin Orthop Relat Res (2003) 0.77
Bone morphogenetic proteins: relevance in spine surgery. Orthop Clin North Am (2002) 0.76
Sciatic neuritis after lumbar decompression surgery. Spine (Phila Pa 1976) (2013) 0.75
Spinal subdural hematoma following lumbar decompressive surgery: a report of two cases. Wien Klin Wochenschr (2014) 0.75
Electrocardiogram reconstruction from high resolution voltage optical mapping. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75
The Cost Effectiveness of Polyetheretheketone (PEEK) Cages for Anterior Cervical Discectomy and Fusion. J Spinal Disord Tech (2015) 0.75
Gene therapy for spinal applications. Orthop Clin North Am (2002) 0.75
Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva. JAMA Ophthalmol (2014) 0.75